How has Acadia Pharmaceuticals's other commercial liabilities changed year-over-year?

Acadia Pharmaceuticals's other commercial liabilities increased by 3.1% year-over-year, from $284.44M to $293.28M.

What is the long-term trend for Acadia Pharmaceuticals's other commercial liabilities?

Over 5 years (2020 to 2025), Acadia Pharmaceuticals's other commercial liabilities has grown at a 22.3% compound annual growth rate (CAGR), from $97.47M to $266.21M.

Acadia Pharmaceuticals ACAD Other Commercial Liabilities

Other Commercial Liabilities at other companies

Catalyst PharmaceuticalCPRX

——

Arrowhead ResearchARWR

——

Praxis Precision Medicines, Inc.PRAX

——

Jazz PharmaceuticalsJAZZ

——

Ultragenyx PharmaceuticalRARE

——

Supernus PharmaceuticalsSUPN

——

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.87B+37.0%

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's other commercial liabilities?: Acadia Pharmaceuticals (ACAD) reported other commercial liabilities of $293.28M in Q1 2026.
How has Acadia Pharmaceuticals's other commercial liabilities changed year-over-year?: Acadia Pharmaceuticals's other commercial liabilities increased by 3.1% year-over-year, from $284.44M to $293.28M.
What is the long-term trend for Acadia Pharmaceuticals's other commercial liabilities?: Over 5 years (2020 to 2025), Acadia Pharmaceuticals's other commercial liabilities has grown at a 22.3% compound annual growth rate (CAGR), from $97.47M to $266.21M.